Patients using brand-name medicines
Conditions
Interventions
In this study, the educational intervention consisted of pharmacists providing standardized explanations using pamphlets about generic medicine (GE) to patients who preferred brand-name medicines and
s manufacturing approval processes, efficacy, quality, safety, advantages not present in brand-name medicines [e.g., improved bitterness and dosing convenience], economic benefits of using GE, the bac
A sessions were scheduled to take approximately 20 min. The intervention was scheduled for the second visit.
Sponsors
Other
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who have provided informed consent to participate in this study Patients who have previously used generic medicines Patients aged 18 to 74 who are using one or more brand-name medicines of their own request
Exclusion criteria
Exclusion criteria: Patients who wish to use generic medicines for all prescribed medications Patients who have no prior experience with generic medicines Patients who were unable to complete all procedures for VISIT 1 and 2 in accordance with the protocol Patients taking medications to improve cognitive function who were deemed unsuitable due to a lack of understanding regarding the medications Patients taking psychotropic medications, such as antidepressants or antipsychotics, who were deemed unsuitable due to the high likelihood of causing excessive distress
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of patients using brand-name medicines before and after the pharmacist-led educational intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in knowledge and perception regarding generic medicine | — |
Countries
Japan
Contacts
Public ContactTomohiko Tairabune
UNIMAT LIFE Co, Ltd, Regina Pharmacy Jimbo-cho Regina Pharmacy Jimbo-cho
Outcome results
None listed